Research and Markets (http://www.researchandmarkets.com/research/x36tcb/blood_disorders) has announced the addition of the "Blood Disorders Pipeline Database - 2016" report to their offering.

Blood Disorders Pipeline Highlights Database - 2016, provides most up-to-date information on key pipeline molecules in the global Blood Disorders Drug market. It covers emerging therapies for Blood Disorders in active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Neutropenia, Sickle-cell Disorders, Thalassemia, Iron deficiency anemia, Haemophilia A, and Haemophilia B. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:

The report presents pipeline by Blood Disorders indications. Key indications covered in this report include Neutropenia, Sickle-cell Disorders, Thalassemia, Iron deficiency anemia, Haemophilia A, and Haemophilia B.

By Clinical Trial Stages:

The report provides Blood Disorders pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:

The report provides Blood Disorders pipeline molecules by their dominant drug mechanism class. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:

The report provides Blood Disorders pipeline molecules by the developing company and the partnered company.

SUMMARY:

- Blood Disorders Pipeline by Indication

- Blood Disorders Pipeline by Clinical Trial Phase

- Blood Disorders Pipeline by Drug Mechanism Classes

- Blood Disorders Pipeline by Company

For more information visit http://www.researchandmarkets.com/research/x36tcb/blood_disorders